Nephrology (10-15%) Complete

Question 1

Measuring BP

Answer 1

Question 2

HTN Diagnosis algorithm

Answer 2

Question 3

Hypertension:
– If NO nocturnal dip (sufficient dip >10% drop ) —> associated with increased risk of ___________________

Answer 3

– If NO nocturnal dip (sufficient dip >10% drop ) —> associated with increased risk of CV events

Question 4

• All patients being treated for HTN should be monitored for new appearance of ________________ (as per CDA guidelines)

Answer 4

• All patients being treated for HTN should be monitored for new appearance of DM (as per CDA guidelines)

Question 5

In Htn: ___________ is recommended with ≥3 risk factors of CVD or with established atherosclerotic disease, regardless of age

Answer 5

In Htn: Statin therapy is recommended with ≥3 risk factors of CVD or with established atherosclerotic disease, regardless of age

Question 6

Secondary HTN causes

Answer 6

Question 7

Hyperaldosteronism

Answer 7

Question 8

HTN 2020 – Renovascular HTN

Answer 8

Question 9

FMD related renal artery stenosis

Answer 9

Question 10

Hypertension Goals

Answer 10

Question 11

High risk patient (“SPRINT” trial Candidates)

Answer 11

Question 12

HTN: Treatment: Lifestyle

Answer 12

Question 13

HTN: First-Line Therapy

Answer 13

Question 14

Diabetes and HTN

Answer 14

Question 15

Renovascular HTN

Answer 15

Question 16

HTNN: Other Special Populations - 1

Answer 16

Question 17

Other Special Populations - 2

Answer 17

Question 18

Other Special Populations - 3

Answer 18

Question 19

HTNN: Response to Therapy

Answer 19

Question 20

Interpreting urine microscopy

Answer 20

Question 21

Anti-GBM disease

Answer 21

Question 22

Pauci-immune / ANCA Vasculitis

Answer 22

Question 23

Pauci-immune / ANCA Vasculitis

Answer 23

Question 24

Immune complex: Low C3

Answer 24

Question 25

Immune complex: Low C4*

Answer 25

Question 26

Immune complex: Low C3/C4

Answer 26

Question 27

Immune Complex: Normal C3/C4

Answer 27

Question 28

IgA Nephropathy treatment

Answer 28

Question 29

Nephrotic syndrome

Answer 29

Question 30

Management of Nephrotic Syndrome

Answer 30

Question 31

Acute interstitial nephritis [AIN]

Answer 31

Question 32

Contrast-Induced Nephropathy
Cholesterol emboli syndrome

Answer 32

Question 33

Rhabdomyolysis

Answer 33

Question 34

Hepatorenal syndrome

Answer 34

Question 35

Causes of AKI in transplant

Answer 35

Question 36

Prevent progression: CKD Targets

Answer 36

Question 37

Statins in ESRD

Answer 37

Question 38

Sick Day Management

Answer 38

Question 39

CKD: Management of Complications

Answer 39

Question 40

CKD: Management of Complications
Anemia

Answer 40

Question 41

CKD - MBD: Management of Complications

Answer 41

Question 42

CKD: Management of Complications

Answer 42

Question 43

CKD: Management of Complications

Answer 43

Question 44

CKD: Management of Complications

Answer 44

Question 45

Uremic Symptoms on History

Answer 45

Question 46

Indications for Dialysis

Answer 46

Question 47

CKD and Diabetes

Answer 47

Question 48

CKD and Diabetes: Pharmacotherapy in 2022/2023:
First Line?

Answer 48

Question 49

KDIGO DM/CKD 2022 pharmacotherapy guidelines

Answer 49

Question 50

Metabolic Acidosis

Answer 50

Question 51

Causes of AGMA

Answer 51

Question 52

Causes of Increased Osmolar Gap

Answer 52

Question 53

RTA

Answer 53

Question 54

Hyponatremia correction formula:

Answer 54

Question 55

Hyponatremia: Risk factors for demyelination?

Answer 55

Question 56

Pseudohyponatremia

Answer 56

Question 57

Hyponatremia

Answer 57

Question 58

Free Water Deficit Formula

Answer 58

Question 59

Nephrogenic DI:
Associated with?

Answer 59

Question 60

Hyperkalemia

Answer 60

Question 61

Chronic hypokalemia

Answer 61

Question 62

Kidney biopsy

Answer 62

Question 63

Nephrolithiasis

Answer 63